Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24


Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies.

Blanco-Pérez F, Papp G, Goretzki A, Möller T, Anzaghe M, Schülke S.

Arch Immunol Ther Exp (Warsz). 2019 Jun 20. doi: 10.1007/s00005-019-00551-8. [Epub ahead of print] Review.


A Model for Apoptotic-Cell-Mediated Adaptive Immune Evasion via CD80-CTLA-4 Signaling.

Yakoub AM, Schülke S.

Front Pharmacol. 2019 May 31;10:562. doi: 10.3389/fphar.2019.00562. eCollection 2019.


Mouse Models for Food Allergies: Where Do We Stand?

Schülke S, Albrecht M.

Cells. 2019 Jun 6;8(6). pii: E546. doi: 10.3390/cells8060546. Review.


Organ-Specific Expression of IL-1 Receptor Results in Severe Liver Injury in Type I Interferon Receptor Deficient Mice.

Anzaghe M, Resch T, Schaser E, Kronhart S, Diez C, Niles MA, Korotkova E, Schülke S, Wolfheimer S, Kreuz D, Wingerter M, Bartolomé Rodríguez MM, Waibler Z.

Front Immunol. 2019 May 9;10:1009. doi: 10.3389/fimmu.2019.01009. eCollection 2019.


NFκB- and MAP-Kinase Signaling Contribute to the Activation of Murine Myeloid Dendritic Cells by a Flagellin A:Allergen Fusion Protein.

Moeller T, Wolfheimer S, Goretzki A, Scheurer S, Schülke S.

Cells. 2019 Apr 15;8(4). pii: E355. doi: 10.3390/cells8040355.


The vaccine adjuvant MPLA activates glycolytic metabolism in mouse mDC by a JNK-dependent activation of mTOR-signaling.

Blanco-Pérez F, Goretzki A, Wolfheimer S, Schülke S.

Mol Immunol. 2019 Feb;106:159-169. doi: 10.1016/j.molimm.2018.12.029. Epub 2019 Jan 9.


Virus-Like Particles as Carrier Systems to Enhance Immunomodulation in Allergen Immunotherapy.

Anzaghe M, Schülke S, Scheurer S.

Curr Allergy Asthma Rep. 2018 Oct 25;18(12):71. doi: 10.1007/s11882-018-0827-1. Review.


Immunotherapy with Native Molecule rather than Hypoallergenic Variant of Pru p 3, the Major Peach Allergen, Shows Beneficial Effects in Mice.

Rodriguez MJ, Wangorsch A, Gomez F, Schülke S, Torres MJ, Vieths S, Scheurer S, Toda M, Mayorga C.

J Immunol Res. 2018 Jun 13;2018:3479185. doi: 10.1155/2018/3479185. eCollection 2018.


Interaction of Non-Specific Lipid-Transfer Proteins With Plant-Derived Lipids and Its Impact on Allergic Sensitization.

Scheurer S, Schülke S.

Front Immunol. 2018 Jun 20;9:1389. doi: 10.3389/fimmu.2018.01389. eCollection 2018. Review.


Modular MLV-VLPs co-displaying ovalbumin peptides and GM-CSF effectively induce expansion of CD11b+ APC and antigen-specific T cell responses in vitro.

Gogesch P, Schülke S, Scheurer S, Mühlebach MD, Waibler Z.

Mol Immunol. 2018 Sep;101:19-28. doi: 10.1016/j.molimm.2018.05.017. Epub 2018 May 28.


Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.

Schülke S.

Front Immunol. 2018 Mar 19;9:455. doi: 10.3389/fimmu.2018.00455. eCollection 2018. Review.


Author Correction: Conjugation of wildtype and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo.

Schülke S, Kuttich K, Wolfheimer S, Duschek N, Wangorsch A, Reuter A, Briza P, Pablos I, Gadermaier G, Ferreira F, Vieths S, Toda M, Scheurer S.

Sci Rep. 2018 Feb 6;8(1):2745. doi: 10.1038/s41598-018-20635-3.


Targeting of Immune Cells by Dual TLR2/7 Ligands Suppresses Features of Allergic Th2 Immune Responses in Mice.

Laiño J, Wangorsch A, Blanco F, Wolfheimer S, Krause M, Flaczyk A, Möller TM, Tsai M, Galli S, Vieths S, Toda M, Scheurer S, Schülke S.

J Immunol Res. 2017;2017:7983217. doi: 10.1155/2017/7983217. Epub 2017 Oct 24.


Conjugation of wildtype and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo.

Schülke S, Kuttich K, Wolfheimer S, Duschek N, Wangorsch A, Reuter A, Briza P, Pablos I, Gadermaier G, Ferreira F, Vieths S, Toda M, Scheurer S.

Sci Rep. 2017 Sep 18;7(1):11782. doi: 10.1038/s41598-017-11972-w. Erratum in: Sci Rep. 2018 Feb 6;8(1):2745.


Critical role of mammalian target of rapamycin for IL-10 dendritic cell induction by a flagellin A conjugate in preventing allergic sensitization.

Schülke S, Fiedler AH, Junker AC, Flaczyk A, Wolfheimer S, Wangorsch A, Heinz A, Beckert H, Nagl B, Bohle B, Vieths S, Toda M, Scheurer S.

J Allergy Clin Immunol. 2018 May;141(5):1786-1798.e11. doi: 10.1016/j.jaci.2017.07.002. Epub 2017 Sep 5.


Dendritic cell targeting with C-type lectins for improvement of allergen immunotherapy.

Schülke S, Vieths S.

J Allergy Clin Immunol. 2016 Aug;138(2):568-70. doi: 10.1016/j.jaci.2016.06.006. Epub 2016 Jun 23. No abstract available.


A Fusion Protein Consisting of the Vaccine Adjuvant Monophosphoryl Lipid A and the Allergen Ovalbumin Boosts Allergen-Specific Th1, Th2, and Th17 Responses In Vitro.

Schülke S, Vogel L, Junker AC, Hanschmann KM, Flaczyk A, Vieths S, Scheurer S.

J Immunol Res. 2016;2016:4156456. doi: 10.1155/2016/4156456. Epub 2016 Jun 1.


[Immunological background and pathomechanisms of food allergies].

Schülke S, Scheurer S.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Jun;59(6):723-31. doi: 10.1007/s00103-016-2346-3. Review. German.


Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.

Uhlig KM, Schülke S, Scheuplein VA, Malczyk AH, Reusch J, Kugelmann S, Muth A, Koch V, Hutzler S, Bodmer BS, Schambach A, Buchholz CJ, Waibler Z, Scheurer S, Mühlebach MD.

J Virol. 2015 Sep;89(17):9044-60. doi: 10.1128/JVI.00844-15. Epub 2015 Jun 17.


Prevention of intestinal allergy in mice by rflaA:Ova is associated with enforced antigen processing and TLR5-dependent IL-10 secretion by mDC.

Schülke S, Wolfheimer S, Gadermaier G, Wangorsch A, Siebeneicher S, Briza P, Spreitzer I, Schiller D, Loeschner B, Uematsu S, Ryffel B, Akira S, Waibler Z, Vieths S, Toda M, Scheurer S.

PLoS One. 2014 Feb 7;9(2):e87822. doi: 10.1371/journal.pone.0087822. eCollection 2014.

Supplemental Content

Loading ...
Support Center